What is Precigen's stock-based comp?

Precigen (PGEN) reported stock-based comp of $3.01M in Q1 2026.

How has Precigen's stock-based comp changed year-over-year?

Precigen's stock-based comp increased by 12.3% year-over-year, from $2.68M to $3.01M.

What is the long-term trend for Precigen's stock-based comp?

Over 4 years (2021 to 2025), Precigen's stock-based comp has grown at a -6.0% compound annual growth rate (CAGR), from $13.9M to $10.87M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Precigen PGEN Stock-Based Comp

Stock-Based Comp at other companies

Bristol-Myers SquibbBMY

$146M+1.4%

Regeneron PharmaceuticalsREGN

$257.4M+0.7%

Gilead SciencesGILD

$218M+4.3%

Viridian Therapeutics, Inc.VRDN

$13.39M+31.0%

Agios PharmaceuticalsAGIO

$15.54M+36.8%

Apogee Therapeutics, Inc.APGE

$17.16M+54.2%

Other financials

Income statement

See full

Revenue$23.3M+1,634%

Operating income-$6.0M+73.5%

Net income-$7.9M+85.4%

EPS (diluted)-$0.02+88.9%

Balance sheet

See full

Cash & equivalents$7.5M+23.5%

Total debt$98.3M+1,714%

Total equity$20.2M+244%

Total assets$138.6M+7.6%

Cash flow

See full

Operating cash flow-$43.8M-168%

CapEx$258.0K-58.5%

Free cash flow-$44.1M-160%

Valuation

See full

Market cap$1.91B+213%

Enterprise value$2B+234%

P/S72×—

Profitability

See full

Gross margin83.6%—

Operating margin-2,890.9%—

Net margin-3,656%—

FCF margin-1,756.5%—

Returns & leverage

See full

Return on equity-843.6%-1,103pp

Debt / equity4.9×—

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Precigen's stock-based comp?: Precigen (PGEN) reported stock-based comp of $3.01M in Q1 2026.
How has Precigen's stock-based comp changed year-over-year?: Precigen's stock-based comp increased by 12.3% year-over-year, from $2.68M to $3.01M.
What is the long-term trend for Precigen's stock-based comp?: Over 4 years (2021 to 2025), Precigen's stock-based comp has grown at a -6.0% compound annual growth rate (CAGR), from $13.9M to $10.87M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.